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Abstract 
Electron transfer from all respiratory chain dehydrogenases of the electron transport chain (ETC) 
converges at the level of the quinone (Q) pool. The Q redox state is thus a function of electron input 
(reduction) and output (oxidation) and closely reflects the mitochondrial respiratory state. Disruption of 
electron flux at the level of the cytochrome bc1 complex (cIII) or cytochrome c oxidase (cIV) shifts the Q 
redox poise to a more reduced state which is generally sensed as respiratory stress. To cope with 
respiratory stress, many species, but not insects and vertebrates, express alternative oxidase (AOX) 
which acts as an electron sink for reduced Q and by-passes cIII and cIV. Here, we used Ciona intestinalis 
AOX xenotopically expressed in mouse mitochondria to study how respiratory states impact the Q 
poise and how AOX may be used to restore respiration. Particularly interesting is our finding that 
electron input through succinate dehydrogenase (cII), but not NADH:ubiquinone oxidoreductase (cI), 
reduces the Q pool almost entirely (>90%) irrespective of the respiratory state. AOX enhances the 
forward electron transport (FET) from cII thereby decreasing reverse electron transport (RET) and ROS 
specifically when non-phosphorylating. AOX is not engaged with cI substrates, however, unless a 
respiratory inhibitor is added. This sheds new light on Q poise signaling, the biological role of cII which 
enigmatically is the only ETC complex absent from respiratory supercomplexes but yet participates in 
the tricarboxylic acid (TCA) cycle. Finally, we delineate potential risks and benefits arising from 
therapeutic AOX transfer. 
 
Keywords: mitochondria; OXPHOS; quinone pool; ROS; xenotopic expression; alternative oxidase 
(AOX) 
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1. Introduction 
Mitochondria are cellular organelles with vital functions that range from ATP production and redox 
homeostasis to cellular signaling. Consequently, mitochondrial dysfunction is present in a number of 
the most threatening human pathologies including neurodegenerative [1] and cardiovascular diseases 
[2,3], obesity, diabetes mellitus [4,5], malignant cell transformation [6-8] and septic organ failure [9]. 
 
A key component for mitochondrial functions is the electron transport chain (ETC) which consists of 
four multi-subunit protein complexes and their redox partners. i.e. the quinone (Q) pool and 
cytochrome c. NADH:ubiquinone oxidoreductase (cI) and succinate dehydrogenase (cII) facilitate 
substrate oxidation and Q pool reduction (quinone-reducing complexes) whilst cytochrome bc1 complex 
(cIII), cytochrome c and cytochrome c oxidase (cIV or COX) are the quinol-oxidizing components of the 
ETC. Notably, substrate oxidation and transfer of reducing equivalents through the ETC is coupled to 
tricarboxylic acid (TCA) cycle activity via cII and, in addition, to the generation of a proton-
electrochemical gradient by the respiratory complexes cI, cIII and cIV. The mitochondrial membrane 
potential (∆𝜓) is the major component of the proton-electrochemical gradient which itself is 
indispensable for ATP generation and mitochondrial redox homeostasis. Therefore, electron transfer 
from all respiratory chain dehydrogenases converges at the level of the Q pool and controlled electron 
flux through the ETC is the basis for metabolic homeostasis. Conversely, any blockade of cIII and cIV 
results in the Q pool becoming highly reduced thereby disturbing metabolic homeostasis and 
decreasing cellular viability [10,11]. Consequently, controlling the Q reduction state affects ∆𝜓 and ATP 
production and is of vital importance and decisive for health or disease. To cope with respiratory 
impairment, many species, but not insects and vertebrates, express alternative oxidase (AOX), a di-iron 
carboxylate protein which oxidizes the Q-pool in a non-protonmotive fashion [12] thereby acting as an 
electron sink for reduced Q and by-passing cIII and cIV. Such a by-pass of impaired ETC complexes by 
xenotopic expression of AOX has been suggested to alleviate diseases, if not offer a cure [13-15]. 
 
In previous studies, the presence of AOX in models in which ETC complexes have been disrupted has 
proved beneficial in restoring respiratory activity and correcting metabolism in cultured mammalian 
cells [16-18], fruit flies [19-22] and mice [23]. Furthermore, AOX conferred resistance to cyanide toxicity 
[24,25] and decreased lethality from sepsis [26]. Confusingly, AOX expression, however, had 
detrimental consequences in a mouse model of mitochondrial myopathy [11]. We thus sought to revisit 
mechanisms of ETC control in an attempt to determine how AOX expression interferes with 
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mammalian bioenergetics. Using isolated heart mitochondria from mice xenotopically expressing Ciona 
intestinalis AOX [25], we show that respiratory activity of cII, but not cI, causes a rapid reduction of Q 
(Qr > 90%) of total Q (Qt). Importantly, a high Qr/Qt state is a condition favoring reverse electron 
transport (RET) [10], a signaling event of pathophysiologic relevance, but has only a marginal impact on 
forward electron transport (FET). In different species, a high Qr/Qt state has also been identified as a 
pre-requisite for the engagement of AOX activity [27,28]. 
 
Here, the use of AOX revealed the extent to which the interplay of the dehydrogenases and oxidases 
defines the direction of electron flow (i.e. RET or FET). Our results also raise the question as to the 
legitimacy of the dual function of cII acting both, as an ETC complex and a member of the TCA cycle. 
Finally, the results presented in this study underline the potential benefits and risks that AOX 
expression may have as a diagnostic tool and/or treatment option. 
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2. Materials and methods 
 
2.1 Mouse model 
 
Ciona intestinalis alternative oxidase (AOX) coding sequence was knocked into the genomic mouse 
Rosa26 locus. AOX expression was controlled by a ubiquitous and strong CAG promoter [25]. Part of 
the animal experiments were conducted under the 1986 UK Animals (Scientific Procedures) Act and 
approved by Home Office licenses (PPL: 7538 and P6C97520A) and local ethical review. All mice were 
kept on a C57Bl6, and WT littermates were used as controls. Animals were maintained in a 
temperature‐ and humidity‐controlled facility, with a 12‐h light/dark cycle and free access to water and 
food. 
 
2.2 Isolation of heart mitochondria 
 
Heart mitochondria from 12-18-week-old mice were isolated as described [29]. Briefly, hearts were 
rapidly removed and transferred to ice-cold MMSE-A buffer (225 mM D-mannitol (Sigma-Aldrich, 
M4125), 20 mM MOPS (Sigma, M1254), 75 mM sucrose (Sigma, S7903), 1 mM ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA, Sigma-Aldrich, E4378), 0.5 mM DL-dithiothreitol 
(DTT, Sigma, 43819), pH7.4). All further steps were performed on ice. Heart tissues were minced using 
scissors and manually pottered in a glass-on-Teflon homogenizer until homogenous in MMSE-B buffer 
(MMSE-A buffer plus 0.05% nagarse, Sigma, P8038). Nagarse activity was stopped by 1:30 dilution of 
the homogenate in MMSE-A buffer. The homogenate was centrifuged at 2,000xg for 4 min at 4 °C and 
the supernatant passed through cheesecloth. The flow-through was centrifuged at 12,000xg for 10 min 
at 4 °C and the pellet resuspended in ice-cold MMSE-C buffer (225 mM D-mannitol, 20 mM MOPS, 75 
mM sucrose, 0.1 mM EGTA, 75 mM KCl, pH7.4). Mitochondrial protein content was estimated using 
bicinchoninic acid assay (Pierce BCA Protein Assay Kit, Thermo Scientific, 23225) with bovine serum 
albumin used as standard. 
 
2.3 Blue-native (BN) gel electrophoresis 
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Blue-native (BN) and BN/BN gel electrophoresis, complex I in-gel activity staining and sample 
preparations were performed as previously described [30,31] using ~3% digitonin (Serva, 19551) and 
0.02% n-dodecyl 𝛽-maltoside (GLYCON Biochemicals, D97002-C) as detergents. 
 
2.4 Western blot analysis 
 
Blue-native (BN)/BN gels were blotted onto polyvinylidene difluoride (PVDF) membranes as described 
[30] and probed with custom-made AOX anti-serum (1:10,000; 21st Century Biochemicals) [17]. Goat 
anti-rabbit IgG (whole molecule)-Peroxidase antibody (Sigma, A0545) served as secondary antibody. 
Enhanced chemiluminescence (ECL) was used and the signal detected in a ChemiDoc XRS (Bio-Rad). 
 
2.5 Complexome profiling 
 
A first dimensional BN electrophoresis gel was stained with Coomassie Brilliant Blue G 250 (Serva, 
17524) and the appropriate lane was cut into 96 fractions. Proteins in the gel fractions were digested 
using trypsin (Promega, V5111) and analyzed by mass spectrometry (MS) essentially as described [32]. 
MS data were analyzed by MaxQuant (v1.5.2.8) [33]. Proteins were identified using a mouse reference 
proteome database UniProtKB released in 6/2015 supplemented with Ciona intestinalis AOX. Enzyme 
specificity was set to trypsin. Acetylation (+42.01) at N-terminus, oxidation of methionine (+15.99), 
deamidation of asparagine and glutamine were selected as variable modifications and 
carbamidomethylation (+57.02) as fixed modification on cysteines. The false discovery rate (FDR) for 
the identification of proteins and peptides was 1%. Intensity-based absolute quantification (IBAQ) 
values were recorded. Protein abundance within native lanes were normalized to maximum 
appearance. Slice numbers of the maximum appearance of mitochondrial complex III dimer (483 kDa), 
complex IV (213 kDa), complex V (538 kDa) and respiratory supercomplex containing complex I, III 
dimer and one copy of complex IV (1676 kDa) were used for native mass calibration. The mass 
spectrometry proteomics data have been deposited to the ProteomeXchange [34] Consortium via the 
PRIDE [35] partner repository with the dataset identifier PXD014016. 
 
2.6 Respirometry and mitochondrial ROS measurements 
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Mitochondrial oxygen consumption was measured using high-resolution respirometry (O2k oxygraph, 
Oroboros Instruments, Innsbruck, Austria) at 30 °C [36] in air-saturated medium (200 nmol O2/ml at 95 
kPa). Weight-specific oxygen consumption was calculated from the time derivative of the oxygen 
concentration (DatLab 7 software, Oroboros Instruments, Innsbruck, Austria). Respiration of isolated 
heart mitochondria (0.03 mg protein per ml) was measured in MMMP-K buffer (120 mM D-mannitol, 20 
mM MOPS, 5 mM KH2PO4, 60 mM KCl, 5 mM MgCl2, pH7.4) in the presence and absence of substrates 
and inhibitors as described [37]. Briefly, we used complex I substrates 10 mM pyruvate (P, Pyr, Sigma, 
P5280), 10 mM glutamate (G, Glu, Aldrich, 49621), 2 mM malate (M, Mal, Sigma, M1000); complex II 
substrate 10 mM succinate (Succ, Sigma-Aldrich, S2378) in presence or absence of 1.5 µM rotenone 
(ROT, Sigma-Aldrich, R8875); adenosine 5′-diphosphate (ADP, Sigma, A2754) as indicated; 5 μM 
carboxyatractyloside (CAT, Calbiochem, 21-620), antimycin A (AA, Sigma, A8674) as indicated; azide 
(Az, Sigma-Aldrich, S2002) as indicated; 1 μM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone 
(FCCP, Sigma, C2920); 2.5 µM oligomycin (Sigma, O4876); 100 µM n-propyl gallate (n-PG, Sigma, 
P3130). 
 
Mitochondrial ROS production was measured in parallel to oxygen consumption by attaching a 
fluorometer module to the respirometer and using a probe specific for the detection of H2O2 production 
[38]. Briefly, 10 µM of Amplex UltraRed Reagent (Invitrogen, A36006), 1 U/ml of peroxidase from 
horseradish (Sigma, P8250) and 5 U/ml of superoxide dismutase (SOD, Sigma, S8409) were added to 
the chamber before starting the measurement. The raw fluorescence signal was calibrated to H2O2 
concentrations of a standard H2O2 solution in the presence of isolated heart mitochondria. 
 
2.7 Qr/Qt measurements 
 
Mitochondrial respiration and the level of Q-pool reduction were simultaneously measured 
voltametrically in a custom-made chamber using an oxygen electrode and a glassy carbon electrode 
and a platinum electrode connected to an Ag/AgCl electrode for reference essentially as previously 
described [39]. 
 
2.8 Measuring mitochondrial membrane potential (∆𝜓) 
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∆𝜓 was monitored fluorimetrically using 2 μM of the ∆𝜓-sensitive probe Safranin O (Sigma-Aldrich, 
S2255) as described [40]. The fluorescence signal was detected as arbitrary units (a.u.) and the signal 
after uncoupling with 1 μM FCCP served as zero value. ∆𝜓 is shown as positive value reciprocal to the 
fluorescence signal. 
 
2.9 Statistical analyses 
 
Statistical analyses were performed using GraphPad Prism (GraphPad Software, version 7.0d). 2way 
ANOVA was used for comparisons of at least n = 3 independent experiments and a P value <0.05 was 
considered being statistically significant. All data are shown as mean. Error bars represent standard 
deviations (SD). 
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3. Results 
 
3.1 AOX forms homo-oligomers but does not affect the assembly or stoichiometry of other ETC complexes 
 
We first sought to determine if AOX activity requires the recognition of specific interaction partners or 
if its presence affects the composition or stoichiometries of the native mouse ETC complexes. We 
studied this using digitonin-solubilized heart mitochondria separated by blue-native (BN) 
polyacrylamide gel electrophoresis [41,42]. Two mutually complementary strategies were followed. 
First, we digested individual gel slices by trypsin and performed mass spectrometry analysis to 
compose a mitochondrial complexome migration profile (Fig. 1A) [32]. In parallel, we incubated BN first 
dimensions with the more stringent detergent n-dodecyl 𝛽-maltoside (DDM) to in-gel dissociate high-
molecular weight assemblies [30] and separated DDM-treated lanes in a second dimension (BN/BN) 
(Fig. 1B,C). Together, both approaches failed to identify AOX interaction partners apart from the 
previously described homomeric high-molecular AOX assemblies (circles in Fig. 1B,C) [25]. Importantly, 
AOX did not cluster with any mitochondrial protein or ETC complex with similar migration pattern (Fig. 
1A), and ETC complexes showed regular migration patterns, protein composition and supercomplex 
stoichiometries (supplementary table S1; PRIDE dataset PXD014016). Taken together, our data confirm 
a xenotopically expressed tunicate AOX in the mouse as a freely diffusible redox partner. 
 
3.2 AOX maintains phosphorylating respiration with cI substrates 
 
A freely diffusible redox partner may pose a metabolic threat if it allows an uncontrolled ETC by-pass 
since electron flux through the AOX is non-protonmotive [43]. Recent experiments in which 
trypanosomal AOX allowed maximal NADH oxidation in submitochondrial particles from bovine heart 
seemingly support this notion [44]. Earlier, we observed that global AOX expression exerts no 
deleterious effects on the general mouse physiology whilst conferring resistance to systemic cyanide 
application [25], which may be accounted for by the inability of AOX to effectively compete with cIII for 
respiratory flux [45]. We tested this assumption in isolated intact mitochondria and found that there 
was little to no engagement of AOX during cI activity as reflected by the respiratory control index (RCI) 
of 6.9 ± 1.7 (mean ± SD, n = 8) in wild-type (WT) and 4.9 ± 1.5 (n = 7) in AOX mitochondria (Fig. 2A,B) 
when energized with pyruvate, glutamate and malate (PGM). Such respiration was not sensitive to n-
propyl gallate (n-PG), a potent AOX inhibitor. The observed decrease in AOX RCI is based on a slightly 
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higher rate of non-phosphorylating respiration (state 4), i.e. respiration upon ADP turnover or upon 
inhibition of the adenine nucleotide translocase (ANT) by carboxyatractyloside (CAT) (Fig. 2B). This 
indicates that in the absence of respiratory inhibition only approx. 7% (or 14 nmol O2/mg/min, blue 
trace in Fig. 2B) of the total electron flow is diverted to AOX. Another bioenergetic parameter for 
estimating the efficiency of oxidative phosphorylation is the ADP/oxygen ratio, or P/O value. It refers to 
the number of moles of ADP phosphorylated to ATP per two electrons flowing through the ETC to 
oxygen. P/O values for isolated WT and AOX heart mitochondria for different substrate combinations 
(supplementary Fig. S1F) are largely in agreement with literature values. Note, inhibition of two proton 
pumps, i.e. cIII and cIV by the addition of cIV inhibitor azide (Az), decreases the P/O value for AOX 
respiration driven by cI substrates PGM to one coupling site. It should be emphasized, however, that 
such measurements are notoriously inaccurate as they assume state 4 respiration (the proton leak) 
ceases during phosphorylating conditions which is obviously not the case when AOX is engaged 
(supplementary Fig. S1B). Under these conditions P/O ratios via an oxygen electrode are unreliable as 
the so-called state 4 respiration is too high (~200 nmol O2/mg/min) to distinguish any measurable 
change in rate upon addition of ADP. 
 
We reasoned that the inability of AOX to be engaged as a terminal oxidase, despite seemingly optimal 
conditions, may be due to its high KM for Qr [28]. Therefore, we determined Qr/Qt ratios (in %) in 
parallel to respiratory rates in WT and AOX heart mitochondria energized by PGM using a Q-electrode 
[39]. Surprisingly, Qr/Qt values remained low (~13% Qr/Qt; Fig. 2C) and did not differ despite changing 
respiratory states. The failure to reach a critical threshold of Qr/Qt (blue horizontal bar in Fig. 2C) 
[27,28] in principle impedes an AOX engagement. In contrast, under conditions of known Q-pool 
reduction [28] such as upon cIII (antimycin A, AA) or cIV (azide, Az) inhibition, AOX expression allows 
respiratory rates in excess of 200 nmol O2/mg/min (blue traces in Fig. 2E,F; supplementary Fig. S1A,B). 
Moreover, inhibitor titrations in AOX-expressing mitochondria resulted in a non-linear dependency of 
the respiratory rate as the levels of Qr increase [28] under non-phosphorylating conditions (Fig. 2F; 
supplementary Fig. S1B). The fact that AA and Az evoked similar responses make unspecific toxic 
inhibitor effects unlikely and Qr release due to a loss of supercomplex integrity was ruled out by 
measuring cI activity on a BN gel (supplementary Fig. S1C). Importantly, despite being non-
protonmotive [43], AOX indirectly maintained ∆𝜓 in PGM energized mitochondria in the presence of 
AA (Fig. 2D) [46]. Such a finding is substantiated by the result that subsequent addition of cI inhibitor 
rotenone (ROT) collapses ∆𝜓 (Fig. 2D). This demonstrates that AOX can act as an effective electron 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
Szibor et al. 
11 
sink in vivo allowing phosphorylating (state 3) respiration on cI substrates when electron flux through 
the ETC downstream of Q is blocked. 
 
3.3 AOX facilitates succinate-dependent FET under high protonmotive force 
 
Similar to AOX, cII is also non-protonmotive and succinate oxidation has previously been shown to 
rapidly increase Qr/Qt levels to approx. 90% [28]. Since succinate is a TCA substrate, it is plausible that 
cII and AOX together may form a futile respiratory cycle with detrimental consequences on cell 
viability. Our previous results suggest that an activation of such futile cycle does not happen in the AOX 
mouse under non-stressed conditions [25]. To understand the mechanistic basis for this paradox, we 
energized isolated heart mitochondria with succinate and measured respiratory rates in the presence of 
ROT (Fig. 3A). Our data reveal that succinate rapidly reduces the Q-pool above a critical threshold (blue 
horizontal bar in Fig. 3B) without generating relevant amount of mitochondrial reactive oxygen species 
(ROS) under any respiratory state (Fig. 3C) and that the presence of AOX does indeed enhance 
mitochondrial respiratory rates both under phosphorylating (presence of ADP, state 3) and non-
phosphorylating (absence of ADP, state 4) conditions (Fig. 3A). Diversion of electron flux through AOX 
is also reflected by a decrease in RCI from 3.2 ± 0.5 (mean ± SD, n = 5) in WT to 1.3 ± 0.1 (n = 7) in AOX 
mitochondria (supplementary Fig. S1D,E). Interestingly, the respiratory rate has little, if any, effect on 
the Qr/Qt ratios (Fig. 3B). Similar to cI substrates, ∆𝜓 is still maintained during succinate-driven 
respiration (Fig. 3D), suggesting that even in the presence of AOX, a significant proportion of the 
electron flux is mediated via the proton-pumping activities of cIII and cIV (representative traces shown 
in Fig. 3E,F). P/O values were also calculated for succinate-dependent respiration in WT heart 
mitochondria (supplementary Fig. S1F). As indicated previously, AOX activity is a complicating factor 
during succinate-dependent respiration (both in the presence and absence of ADP, respectively). This 
prevents any accurate calculation of P/O values with AOX respiring mitochondria. In support of such a 
notion, it is apparent from the original respiratory traces (supplementary Fig. S1D,E) that the P/O ratio 
of isolated AOX heart mitochondria must be significantly lower than in WT even if an accurate number 
cannot be reliably determined because of the high basal respiratory rate. 
 
3.4 AOX prevents RET under non-phosphorylating conditions 
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Succinate accumulation along with high ∆𝜓 and Qr/Qt has been described as mechanism for RET [10] in 
ischemia-reperfusion injury and inflammatory diseases [26,47,48]. For the latter, AOX was 
demonstrated to have beneficial effects [26]. The bioenergetic rationale for such beneficial effects was 
believed to depend upon the ability of AOX to maintain the Q-pool in a more oxidized state in 
comparison to WT mitochondria thereby reducing RET-mediated ROS production [10,25]. We sought 
to test if this was the case by determining how AOX exerts its effects on mitochondrial respiration on 
succinate in the absence of ROT and thus in the presence of a fully functional cI. Again, isolated heart 
mitochondria expressing AOX were used and we discovered enhanced succinate-driven respiration 
under non-phosphorylating conditions (Fig. 4A; supplementary Fig. S1G). Although the addition of 
small amounts of ADP increased respiration in WT mitochondria, the presence of AOX had no additive 
effect (Fig. 4A; supplementary Fig. S1G). The addition of saturating amounts of ADP failed to induce 
sustained phosphorylating respiration (Fig. 4A; supplementary Fig. S1G) both in WT and AOX heart 
mitochondria. This was previously attributed to a loss of ∆𝜓 and the generation of the potent cII 
inhibitor oxaloacetate [49]. As demonstrated here (Fig. 4D), such a notion is not supported by ∆𝜓 
measurements (original traces shown in Fig. 4E,F). Although addition of ADP severely diminished the 
magnitude of ∆𝜓, the fact that it is restored upon ANT inhibition by CAT (Fig. 4D), suggests that the 
observed depolarization is due to ATP/ADP exchange and not due to a proposed inhibition of cII activity 
[49]. In support of this notion, respiratory uncoupling by carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) following CAT fully depolarizes ∆𝜓 (Fig. 4D-F). 
Furthermore, measurements of the steady-state redox poise of the Q-pool in the absence of ROT 
showed that the pool is highly reduced irrespective of the respiratory state and presence or absence of 
ADP and/or AOX (Fig. 4B). Although the subsequent addition of PGM and/or ROT in the presence of 
succinate dramatically increased respiratory rates (Fig. 4A; supplementary Fig. S1G) addition of ROT 
caused negligible Q oxidation (Fig. 4B). Of particular importance is the observation that the presence of 
AOX, in the absence of ROT, substantially reduces ROS production in comparison to WT mitochondria 
(Fig. 4C; supplementary Fig. S1H) both in the presence of succinate alone or under non-phosphorylating 
conditions. Such results indicate that under pathologic conditions, AOX can shift the electron flux 
through the ETC from RET (and ROS) towards FET. 
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4. Discussion 
 
In the present study, we confirm that AOX from the tunicate Ciona intestinalis functions as a freely 
diffusible mitochondrial oxidase potentially without mobility restrictions when xenotopically expressed 
in the mouse (Fig. 1A). This may seem surprising considering the formation of high-molecular weight 
assemblies which have previously been described as mainly homo-oligomers of dimers [25]. Indeed, it is 
unclear thus far, which assembly stoichiometry may constitute the most active AOX form in the mouse 
in vivo. Interestingly, the expression of AOX as dimer was first described for plants and its reduction 
state was related to its catalytic activity [50]. Later it was proposed that AOX dimerization is common 
to all AOXs and that such assemblies may be of mechanistic or structural importance [12,51,52]. 
Respiratory stress may result in the buildup of reducing equivalents within the mitochondrial matrix 
thereby facilitating the reduction of regulatory residues, e.g. cysteines forming disulfide bonds [50]. It is 
unlikely, however, that this mechanism controls AOX activity in its host Ciona intestinalis since this 
tunicate AOX does not contain the conserved cysteine residues necessary for activation as is the case in 
plants. How homo-oligomerization of xenotopically expressed tunicate AOX in the mouse affects its 
catalytic engagement cannot be concluded with absolute certainty to date, however, it is obvious from 
this and previous studies that a xenotopically expressed tunicate AOX is highly active. Furthermore, 
apart from the formation of homo-oligomers, AOX association with supercomplexes has never been 
demonstrated although it is conceivable, albeit unlikely, that the inclusion of digitonin may have 
removed AOX from high-molecular structures. Altogether, this supports the notion that xenotopically 
expressed AOX acts as a freely diffusible redox partner. Indeed, when trypansomal AOX was added to 
submitochondrial particles (SMPs) in the presence of cyanide, respiratory activity was restored [44] 
from which it was concluded that Q channeling in mitochondrial supercomplexes does not exist. We 
found, however, that in isolated mouse heart mitochondria respiring on cI substrates in the absence of 
respiratory inhibitors AOX only marginally affected the RCI suggesting that under these conditions 
AOX was barely engaged (Fig. 2B). Such a lack of engagement was substantiated by the discovery that 
in the absence of respiratory inhibitors the Q-pool is insufficiently reduced by cI to maintain AOX 
activity (Fig. 2C). Addition of respiratory inhibitors, however, engages AOX both under phosphorylating 
(state 3) [25] and non-phosphorylating (state 4) conditions (Fig. 2E,F; supplementary Fig. S1A,B) whilst 
maintaining ∆𝜓 (Fig. 2D). Of course, the measured global Qr/Qt ratio cannot exclude different local 
Qr/Qt conditions, for instance in a putative compartment within respirasomes between cI and cIII [53]. 
The fact that AOX and Q are freely diffusible, yet cI substrates do not support high AOX respiration, 
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however, indicate that such high Qr/Qt ratios are not achieved or immediately decreased through 
oxidation by cIII. Titration of cI activity with AA or Az, however, resulted in an exponential increase in 
the presence of AOX (Fig. 2F; supplementary Fig. S1B) suggesting that the pool is accessible to AOX 
under all Qr/Qt ratios. This is of importance for the biological function of AOX, e.g. during stress 
response. It has recently been shown in its natural host, Ciona intestinalis, that AOX transcript levels are 
upregulated upon exposure to hypoxia and by sulfide, a potent cIV inhibitor, whilst being unresponsive 
to other environmental stressors such as physiologically stressful temperature or heavy-metal exposure 
[54]. Here, due to the genetic design, AOX transcript level cannot directly correlate with its catalytic 
function. In fact, our results explain the lack of a detrimental phenotype when AOX protein is 
ubiquitously expressed in the mouse despite its ability to resist cyanide intoxication [24,25]. 
 
Although, AOX confers resistance to cyanide, the failure to rescue a COX15 knock-out in mouse skeletal 
muscle at first appeared somewhat mysterious. However, it may be explained by the fact that under 
disease and respiratory stress conditions, the metabolic situation is different. One major difference 
between the acute application of cyanide and the permanent ablation of COX15 is that the long-term 
disruption of signaling cascades required for mitochondrial biogenesis and muscle repair may outweigh 
potential benefits such as a decreased ROS load. In contrast, succinate accumulation and RET induction 
has been described for the post-ischemic heart and sepsis [26,47] and for the latter AOX expression 
showed beneficial effects [26]. Of note, all aforementioned examples concentrate on a putative effect 
of AOX on pathophysiologic conditions while seemingly ignoring physiological signals originating from 
the respiratory chain. In fact, some stress responses related to mitochondrial dysfunction viewed as 
detrimental thus far, such as ROS emitted from COX15 deficient mitochondria [11], are now recognized 
as essential for adaptive remodeling, mitochondrial biosynthesis and survival. In other words, 
mitochondrial ROS may be of vital importance for adaptation and thus having physiological relevance. 
This is specifically true for oxygen sensing in the pulmonary vasculature [55] and glomus cells of the 
carotid body [56]. In both cases, signals from the respiratory chain are required, and an increase of the 
Qr/Qt ratio can safely be assumed or has been demonstrated. It is tempting to speculate how AOX 
would interfere with oxygen sensing in the two cell types considering their specific physiological 
function and what role succinate may play under such conditions. In an attempt to replicate the above-
described metabolic situations, we tested AOX heart mitochondria in the presence of succinate plus 
ROT (to prevent RET) and observed high respiratory activity even in the absence of ADP which, 
importantly, was associated with a dramatic decrease in the RCI (also seen as high state 4 respiration in 
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Fig. 3A) suggesting that AOX was engaged. Since cII is generally not present in supercomplex 
assemblies, the observed respiration is likely based on random collision of the three independent freely 
diffusible redox partners, i.e. cII, the Q pool and AOX. Qr/Qt measurements revealed that in the 
presence of cII substrate succinate, irrespective of the presence or absence of ROT, another criterion for 
AOX engagement is fulfilled, namely the presence of high Qr/Qt ratios (Fig. 3B; 4B). In plants, 
engagement of the alternative respiratory pathway occurs only when Qr/Qt ratios reach critical 
thresholds of 35-40% (blue horizontal bars in Fig. 2C; 3B; 4B) [27,28]. Previously, Ciona intestinalis AOX 
expressed in mouse skeletal muscle has revealed strikingly similar Qr/Qt values for catalytic 
engagement [11]. Surprisingly, we found AOX to be regularly engaged during cII respiration under non-
phosphorylating (state 4) but not phosphorylating (state 3) conditions although never achieving 
maximal respiratory rates (Fig. 3A; 4A) suggesting there is some restriction of electron flow. 
Importantly, our findings demonstrate that any observed restriction f electron flow is not necessarily 
due to a lack of Q-pool reduction as Qr levels remain high (Fig. 3B; 4B). It may be due to a loss of ∆𝜓 
[49] although addition of ADP depolarizes ∆𝜓 which is CAT-insensitive and thus not due to 
phosphorylation (Fig. 3D-F; 4D-F). Obviously, some electron flux continues to be mediated by cIII as ∆𝜓 
is still maintained even with AOX. The finding that electron flux through AOX, in the absence of ROT, is 
very low may suggest that the regulated element may be cII itself, possibly as a result of oxaloacetate 
accumulation [49]. If AOX is engaged, however, it supports respiration and abolishes mitochondrial 
ROS production by RET in a similar manner to ADP addition (Fig. 4A,C). Altogether, our data support 
the notion that in vivo succinate is unlikely to be a major respiratory substrate since a non-
phosphorylating respiratory shunt (cII-Q-AOX), would inevitably lead to a severe, non-viable, 
phenotype which is obviously not the case [25]. 
 
Interestingly, the Qr/Qt ratios appear unaffected by any changes of the respiratory state (Fig. 2C; 3B; 
4B). Thus, although Qr is fully reduced and potentially accessible to AOX, respiration is low under 
phosphorylating (state 3) yet high under non-phosphorylating (state 4) conditions (Fig. 4A; 
supplementary Fig. S1G). A high electron flux through cII in the presence of oxaloacetate is not likely 
and contrary to expectations a decrease in the Qr/Qt ratio was not observed. More importantly, when cI 
substrates were added to the mitochondria we observed an increase in phosphorylating, oligomycin-
sensitive, respiration and a decrease in ROS production (supplementary Fig. S1G,H). Such stimulation, 
however, is not solely dependent on an increase in ∆𝜓 or electron flow through cI since ROT addition 
showed the same result (Fig. 4A,C). This finding raises questions regarding the true function of cII in 
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vivo in health and disease. We propose that under disease conditions, cII-induced RET may be a pivotal 
signal for adaptation. Under all other conditions, regular succinate levels in the presence of ADP, RET 
and FET seem to be restricted by a number of possible factors, including cI presence and, may be, its 
catalytic activity. The fact that a minimum of 84% of cI is complexed in respiratory supercomplexes [42] 
suggests that some sort of Q flux control or Q compartmentalization may be potentially a reason for 
the development of supercomplexes. 
 
In conclusion, xenotopically expressed tunicate AOX is a freely diffusible redox partner in mouse 
mitochondria which is catalytically active when the Q pool is highly reduced (summarized in Fig. 5). 
However, respiratory engagement is favored under non-phosphorylating (state 4) conditions generally 
described as respiratory stress. AOX thus is an invaluable tool to investigate respiratory control 
mechanisms and may become a treatment option for mitochondriopathies based on respiratory 
disruption. 
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Figure legends 
 
Fig. 1. AOX acts as a freely diffusible Qr redox partner. (A) Digitonin-solubilized AOX heart 
mitochondria separated by 1D blue-native (BN) polyacrylamide gel electrophoresis, analyzed by mass 
spectrometry. Heat maps of selected protein subunits representing individual respiratory complexes 
with red color representing a high and black color representing a low expression. cI, Ndufs7; cIII, Uqcrc1; 
cIV, Cox4i1; cV, Atp5a1; cII, Sdha. Line-chart to illustrate the migration pattern of classical respiratory 
complexes and AOX assemblies. Note, estimated molecular masses support the notion that AOX 
expressed in the mouse assembles into homo-oligomers mainly consisting of multimers of dimers. (B) 
Coomassie stain of digitonin-solubilized AOX heart mitochondria separated by tandem BN/BN using n-
dodecyl 𝛽-maltoside (DDM) treatment before second dimensional run. (C) AOX protein detected by 
western blot analysis. Of note, the regular pattern of AOX assemblies marked by circles again indicates 
that AOX does not form erratic aggregates but rather assembles into multimers of different 
stoichiometries. Circles from the western blot analysis have been superposed onto the Coomassie 
stained gel to visualize the AOX multimer migration pattern in comparison to other mitochondrial 
complexes. 
 
Fig. 2. AOX is engaged on cI substrates only in the presence of respiratory inhibitors. 
Representative respirometry traces of isolated WT (A) and AOX (B) heart mitochondria respiring on cI 
substrates pyruvate, glutamate and malate (PGM) with adenosine diphosphate (ADP in µM) and 
carboxyatractyloside (CAT) additions as indicated. Respiratory control indices (RCI) shown as mean ± 
SD, WT n = 8, AOX n = 7. (C) Qr/Qt ratios (%) shown as mean ± SD, n = 3. Blue horizontal bar represents 
putative threshold for AOX engagement. (D) Mitochondrial membrane potential (∆𝜓) shown as 
arbitrary units (a.u.) as mean ± SD, n = 3. AA, antimycin A. Grey area indicates significant difference 
between WT and AOX (P < 0.05) analyzed by 2way ANOVA with post-hoc Sidak's multiple comparisons 
test. Representative respiratory rate traces of isolated WT and AOX heart mitochondria in non-
phosphorylating (absence of ADP, state 4) (E) and phosphorylating (presence of ADP, state 3) (F) 
conditions with PGM as substrates. ADP (in µM) and AA (in µM) additions as indicated. 
 
Fig. 3. AOX engages on cII substrate succinate when cI is inhibited. (A) Respiratory rates of isolated 
heart mitochondria shown as mean ± SD, n = 3. ROT, rotenone; ADP in µM. Grey areas indicate 
significant difference between WT and AOX (P < 0.05) analyzed by 2way ANOVA with post-hoc Sidak's 
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multiple comparisons test. (B) Qr/Qt ratios (%) shown as mean ± SD, n = 3. Blue horizontal bar 
represents putative threshold for AOX engagement. (C) Hydrogen peroxide production shown as mean 
± SD, n = 3. (D) Mitochondrial membrane potential (∆𝜓) using safranin O shown as mean ± SD, n = 3. (E) 
Representative trace showing ∆𝜓 under conditions as indicated in WT mitochondria. (F) Representative 
trace showing ∆𝜓 under conditions as indicated in AOX mitochondria. 
 
Fig. 4. AOX engages on cII substrate succinate only under non-phosphorylating conditions. (A) 
Respiratory rates of isolated heart mitochondria shown as mean ± SD, n = 3. ADP in µM; ROT, 
rotenone. Grey areas indicate significant difference between WT and AOX (P < 0.05) analyzed by 2way 
ANOVA with post-hoc Sidak's multiple comparisons test. (B) Qr/Qt ratios (%) shown as mean ± SD, n = 
3. Blue horizontal bar represents putative threshold for AOX engagement. (C) Hydrogen peroxide 
production shown as mean ± SD, n = 3. Grey areas indicate significant difference between WT and AOX 
(P < 0.05) analyzed by 2way ANOVA with post-hoc Sidak's multiple comparisons test. Note the inverse 
relation of hydrogen peroxide production and respiratory rate. (D) Mitochondrial membrane potential 
(∆𝜓) using safranin O shown as mean ± SD, n = 3. Note the lack of membrane potential restoration in 
state 3. (E) Representative trace showing ∆𝜓 under conditions as indicated in WT mitochondria. (F) 
Representative trace showing ∆𝜓 under conditions as indicated in AOX mitochondria. 
 
Fig. 5. Graphical overview on AOX engagement. (A) cI substrates do not allow AOX respiration unless 
cIII and/or cIV are inhibited. AA, antimycin A. (B) cII substrate succinate readily engages AOX when cI is 
inhibited (ROT, rotenone) or in the absence of ADP. Note, ROT acts upstream of Q thus being 
indicative for a cI control mechanism on AOX engagement independent from the Qr/Qt ratio. 
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Supplementary material 
 
Mass spectrometry proteomics data. 
 
Deposited to the ProteomeXchange Consortium via the PRIDE [35] partner repository (dataset 
identifier - PXD014016). 
 
Supplementary table S1. Selected complexome profiles from AOX transgenic mouse heart 
mitochondria (relates to Fig. 1A). 
 
Supplementary Fig. S1. AOX engagement in mitochondrial respiration (relates to Fig. 2E,F; Fig. 3A; 
4A,C). Representative respiratory rate traces of isolated WT and AOX heart mitochondria in 
phosphorylating (presence of ADP, state 3) (A) and non-phosphorylating (absence of ADP, state 4) (B) 
conditions with PGM as substrates. ADP (in µM) and azide (Az, in mM) additions as indicated. (C) cI in-
gel staining of isolated WT and AOX heart mitochondria treated with Antimycin A (AA) as indicated 
separated on a blue-native (BN) gel. BHM, bovine heart mitochondria, used as control. Assignment of 
complexes: S0, supercomplexes containing complex I and III with the stoichiometry of I1III2; S1-3, 
supercomplexes containing complex I, III and IV with the stoichiometry of I1III2IV1-3; SXL, large 
supercomplexes; III2, dimer of complex III or cytochrome c reductase; IV, complex IV or cytochrome c 
oxidase; V, complex V or ATP synthase. Representative respiratory rate traces of isolated WT (D) and 
AOX (E) heart mitochondria in state 3 or state 4 as indicated with succinate as substrate. (F) Table of 
P/O values for isolated WT and AOX heart mitochondria respiring on substrates as indicated. Data are 
shown as mean ± SD of n = 3 measurements. P < 0.05 tested by 1way ANOVA with post-hoc Tukey's 
multiple comparisons test for WT PGM vs. AOX PGM+Az; WT PGM vs. WT Rot/Succ; AOX PGM vs. AOX 
PGM+Az; AOX PGM vs. WT Rot/Succ. PGM, pyruvate, glutamate, malate; Rot, rotenone; Succ, 
succinate. Note, reliable P/O ratios cannot be determined for mitochondria respiring on succinate in the 
presence of AOX. (G) Respiratory rates of isolated heart mitochondria shown as mean ± SD, n = 3. ADP 
in µM; Pyr, pyruvate; Glut, glutamate; Mal, malate; n-PG, n-propyl gallate. Grey areas indicate 
significant difference between WT and AOX (P < 0.05) analyzed by 2way ANOVA with post-hoc Sidak's 
multiple comparisons test. Note, n-PG was added to visualize that respiration in AOX mitochondria was 
indeed due to catalytic AOX engagement under the conditions described. (H) Hydrogen peroxide 
production shown as mean ± SD, n = 3. Grey areas indicate significant difference between WT and AOX 
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(P < 0.05) analyzed by 2way ANOVA with post-hoc Sidak's multiple comparisons test. Note the inverse 
relation of hydrogen peroxide production and respiratory rate. 
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Highlights 
 
 Respiratory inhibition poses metabolic stress leading to human pathologies 
 Changes of the quinone (Q) pool redox poise reflects metabolic states 
 Where expressed, alternative oxidase (AOX) relieves metabolic stress by oxidizing Q 
 Ciona AOX was used to study mouse respiratory control mechanisms 
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